PHARMA SIGNALOPEN RESEARCH PLATFORM →
PHARMASIGNAL DIRECTORY

Drug and Biologic Profiles

Curated drug profiles with sponsors, targets, indications, regulatory status and source links.

cadonilimab

Cervical cancer · Other solid tumors

datopotamab deruxtecan

Breast cancer · Non-small cell lung cancer · Other solid tumors

emicizumab

Hemophilia A

enfortumab vedotin

Urothelial cancer

enzalutamide

Prostate cancer

fezolinetant

Vasomotor symptoms associated with menopause

ivonescimab

Non-small cell lung cancer · Other solid tumors

lecanemab

Alzheimer's disease

lenvatinib

Thyroid cancer · Hepatocellular carcinoma · Renal cell carcinoma · Endometrial cancer

nivolumab

Multiple solid tumors · Hematologic malignancies

satralizumab

Neuromyelitis optica spectrum disorder

tiratricol

Peripheral thyrotoxicosis in MCT8 deficiency

tocilizumab

Rheumatoid arthritis · Giant cell arteritis · Systemic juvenile idiopathic arthritis

trastuzumab deruxtecan

Breast cancer · Gastric cancer · Non-small cell lung cancer · Other HER2-positive solid tumors

zolbetuximab

Gastric cancer · Gastroesophageal junction cancer